Assay Development for Superior Understanding of Response and Efficacy (ASSURE) RRPV-26-07-ASSURE
Summary
AI-generated · Nov 18, 2025Develop innovative, multiplexed, high-throughput, scalable, and sample-sparing assays that provide a comprehensive evaluation of an individual’s immune status in response to infection or vaccination. The effort aims to de-risk the development of novel assay platform technologies and establish new, qualified assays primarily for BARDA and vaccine developers to assess immune responses and status elicited by vaccines or infection due to CBRN threats, pandemic influenza, or other emerging infectious diseases, with some assays potentially supporting new correlates of protection.
The ASSURE program aims to develop innovative, multiplexed, high-throughput, scalable and sample sparing assays that provide comprehensive evaluation of an individual s immune status as a response to either infection or vaccination. This program seeks to de-risk the development of novel assay platform technologies with the ultimate goal of establishing new, qualified assays primarily for BARDA and vaccine developers to comprehensively assess the immune response and status elicited by vaccines and/or infection due to CBRN threats, pandemic influenza, or other emerging infectious diseases. Some of these assays may lead to support of new correlates of protection.
From Solicitation posted on Nov 17, 2025Notice history
1Details
Award Information
Not yet awarded
Contacts
Phone
Agency
Place of Performance
USA